Clinical Utility of the Combined Use of CA19-9 and DUPAN-2 in Pancreatic Adenocarcinoma

CONCLUSIONS: Only patients with normal CA19-9 and DUPNA-2 values should be diagnosed with early-stage PDAC.PMID:38652196 | DOI:10.1245/s10434-024-15221-z

Source: Ann Oncol - April 23, 2024 Category: Cancer & Oncology Authors: Tatsuaki Sumiyoshi Kenichiro Uemura Ryuta Shintakuya Kenjiro Okada Kenta Baba Takumi Harada Masahiro Serikawa Yasutaka Ishii Shinya Nakamura Koji Arihiro Yoshiaki Murakami Shinya Takahashi Source Type: research